James M. Gray

James M. Gray

Auto-generated profile, based on publicly available information

James M. Gray

Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, Cincinnati OH 45229, USA; Department of Pediatrics, University of Cincinnati College of Medicine, 3235 Eden Avenue, Cincinnati, OH 45229, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in The American Journal of Emergency Medicine
Verified
Journal Article
Closed access
JBJames J. Brown
James J. Brown
JGJames M. Gray
James M. Gray
MRMark G. Roback
Mark G. Roback
USUsha Sethuraman
Usha Sethuraman
AFAhmad Farooqi
Ahmad Farooqi
NKNirupama Kannikeswaran
Nirupama Kannikeswaran

14 November 2017 in Pediatric Emergency Care
Verified
Journal Article
Closed access
JGJames M. Gray
James M. Gray
JMJaya D. Maewal
Jaya D. Maewal
SLScott A. Lunos
Scott A. Lunos
RFRonald A. Furnival
Ronald A. Furnival
MHMarissa A. Hendrickson
Marissa A. Hendrickson
Objectives: Ondansetron has been shown to decrease admission rate and the need for intravenous fluids among pediatric emergency department (ED) patients with acute gastroenteritis, but there is limited evidence regarding its use after ED discharge. This study describes prescribing patterns for ondansetron and assesses the effects of ondansetron home prescription on rate of return. Methods: Data were gathered from the electronic health record on 2 separate but overlapping groups of patients seen in a pediatric ED from 2012 to 2014. The Gastroenteritis Group included all patients with a discharge diagnosis of gastroenteritis by International Classification of Diseases, Ninth Revision, code. The All Ondansetron Group included any child prescribed ondansetron at discharge. Patterns of ondansetron use and 3- and 7-day ED return rate were assessed for both groups. Discharge diagnosis was evaluated for the All Ondansetron Group. Results: A total of 996 patients with acute gastroenteritis were identified during the study period. Of these, 76% received ondansetron in the ED, and 71% were discharged with prescriptions for ondansetron. Seven-day ED return rates were similar between groups (6% with prescription, 5% without, P = 0.66). A total of 2287 patients received home prescriptions for ondansetron. Fifty-four percent of these patients' discharge diagnoses were classed as gastrointestinal complaints, 14% other infectious conditions, 9% respiratory, and 4% injuries. Their return rate was 6%. There was wide variation in the number of doses prescribed. Conclusions: Home-use ondansetron is widely prescribed in this urban academic pediatric ED for a variety of indications, without effect on 3- or 7-day ED return. Further prospective studies are necessary to determine the efficacy of this practice.

24 January 2022 in AEM Education and Training
Verified
Journal Article
Closed access
PDF file
JGJames M. Gray
James M. Gray
DSDavid Schnadower
David Schnadower
RLRyan LaFollette
Ryan LaFollette
ASAshish S. Shah
Ashish S. Shah
BSBrad Sobolewski
Brad Sobolewski

19 March 2020 in Pediatric Emergency Care
Verified
Journal Article
Closed access
JGJames M. Gray
James M. Gray
MRMark G. Roback
Mark G. Roback
Autism spectrum disorder (ASD) affects more than 1% of children in the United States, with the rate of new diagnoses climbing significantly in the last 15 years. Emergent conditions and subsequent visits to the emergency department (ED) can be particularly challenging for children with ASD, most of whom also have comorbidities in addition to their deficits in social communication and interaction. In the emergency setting, these conditions can cause a range of behaviors that result in challenges for health care providers and may result in suboptimal experiences for children with ASD and their families. We present the ED course of 3 children with ASD to illustrate these challenges, emphasize successful strategies, and highlight opportunities for improvement.

28 April 2023 in Pediatric Critical Care Medicine
Verified
Journal Article
Closed access
JGJames M. Gray
James M. Gray
TRTia T. Raymond
Tia T. Raymond
DADianne L. Atkins
Dianne L. Atkins
KTKen Tegtmeyer
Ken Tegtmeyer
DNDana E. Niles
Dana E. Niles
FIfor the pediRES-Q Investigators
for the pediRES-Q Investigators
OBJECTIVES: To characterize inappropriate shock delivery during pediatric in-hospital cardiac arrest (IHCA). DESIGN: Retrospective cohort study. SETTING: An international pediatric cardiac arrest quality improvement collaborative Pediatric Resuscitation Quality [pediRES-Q]. PATIENTS: All IHCA events from 2015 to 2020 from the pediRES-Q Collaborative for which shock and electrocardiogram waveform data were available. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We analyzed 418 shocks delivered during 159 cardiac arrest events, with 381 shocks during 158 events at 28 sites remaining after excluding undecipherable rhythms. We classified shocks as: 1) appropriate (ventricular fibrillation [VF] or wide complex ≥ 150/min); 2) indeterminate (narrow complex ≥ 150/min or wide complex 100–149/min); or 3) inappropriate (asystole, sinus, narrow complex < 150/min, or wide complex < 100/min) based on the rhythm immediately preceding shock delivery. Of delivered shocks, 57% were delivered appropriately for VF or wide complex rhythms with a rate greater than or equal to 150/min. Thirteen percent were classified as indeterminate. Thirty percent were delivered inappropriately for asystole (6.8%), sinus (3.1%), narrow complex less than 150/min (11%), or wide complex less than 100/min (8.9%) rhythms. Eighty-eight percent of all shocks were delivered in ICUs or emergency departments, and 30% of those were delivered inappropriately. CONCLUSIONS: The rate of inappropriate shock delivery for pediatric IHCA in this international cohort is at least 30%, with 23% delivered to an organized electrical rhythm, identifying opportunity for improvement in rhythm identification training.

1 October 2019 in Hospital Pediatrics
Verified
Journal Article
Closed access
PDF file
GHGabrielle Z. Hester
Gabrielle Z. Hester
DWDavid Watson
David Watson
ANAmanda J. Nickel
Amanda J. Nickel
NRNicholas Ryan
Nicholas Ryan
BJBryan Jepson
Bryan Jepson
KBKelly R. Bergmann
Kelly R. Bergmann
OBJECTIVES: To develop a model to predict risk of intravenous immunoglobulin (IVIg) nonresponse in patients with Kawasaki disease (KD) to assist in early discharge decision-making. METHODS: Retrospective cohort study of 430 patients 0 to 18 years old discharged from a US children’s hospital January 1, 2010, through July 31, 2017 with a diagnosis of KD. IVIg nonresponse was defined as at least 1 of the following: temperature ≥38.0°C between 36 hours and 7 days after initial IVIg dose, receipt of a second IVIg dose after a temperature ≥38.0°C at least 20 hours after initial IVIg dose, or readmission within 7 days with administration of a second IVIg dose. Backward stepwise logistic regression was used to select a predictive model. RESULTS: IVIg nonresponse occurred in 19% (81 of 430) of patients. We identified a multivariate model (which included white blood cell count, hemoglobin level, platelet count, aspartate aminotransferase level, sodium level, albumin level, temperature within 6 hours of first IVIg dose, and incomplete KD) with good predictive ability (optimism-adjusted concordance index: 0.700) for IVIg nonresponse. Stratifying into 2 groups by a predictive probability cutoff of 0.10, we identified 26% of patients at low risk for IVIg nonresponse, with a sensitivity and specificity of 90% and 30%, respectively, and a negative predictive value of 93%. CONCLUSIONS: We developed a model with good predictive value for identifying risk of IVIg nonresponse in patients with KD at a US children’s hospital. Patients at lower risk may be considered for early discharge by using shared decision-making. Our model may be used to inform implementation of electronic health record tools and future risk prediction research.